Literature DB >> 479590

Eosinophil-mediated killing of schistosomula of Schistosoma mansoni in vitro: synergistic effect of antibody and complement.

D J McLaren, F J Ramalho-Pinto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 479590

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  6 in total

1.  KCl-Extractable surface antigens of Schistosoma mansoni: immunological characterization and applicability in immunodiagnosis.

Authors:  J P Rotmans; G W Mooij
Journal:  Z Parasitenkd       Date:  1982

2.  Maturation in vivo of Schistosoma mansoni schistosomula after culture in vitro with granulocytes and antibody.

Authors:  A Dessein; A E Butterworth; M A Vadas; J R David
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

3.  Interleukin 5 (IL-5) is not required for expression of a Th2 response or host resistance mechanisms during murine schistosomiasis mansoni but does play a role in development of IL-4-producing non-T, non-B cells.

Authors:  L R Brunet; E A Sabin; A W Cheever; M A Kopf; E J Pearce
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

4.  Myeloperoxidase is more efficient than eosinophil peroxidase in the in vitro killing of newborn larvae of Trichinella spiralis.

Authors:  J Buys; R Wever; E J Ruitenberg
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

5.  Complement-dependent killing of Nippostrongylus brasiliensis infective larvae by rat alveolar macrophages.

Authors:  T G Egwang; J Gauldie; D Befus
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

6.  Antibody responses to Schistosoma mansoni schistosomula antigens.

Authors:  Moses Egesa; Lawrence Lubyayi; Frances M Jones; Angela van Diepen; Iain W Chalmers; Edridah M Tukahebwa; Bernard S Bagaya; Cornelis H Hokke; Karl F Hoffmann; David W Dunne; Alison M Elliott; Maria Yazdanbakhsh; Shona Wilson; Stephen Cose
Journal:  Parasite Immunol       Date:  2018-10-14       Impact factor: 2.280

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.